Immunotech Laboratories Inc (IMMB)

[NanoEE]

Short answer, maybe. 50/50 chance.

As long as they can start generating revenue for Enzolytics Inc.. But in order to generate revenue you have to have a good business plan. I have not seen the directive or a future looking statement to ease investors worries. After all this is a penny play information is very little and all cylinders don’t have to fire in order to trade on the OTC.

But the take away here is generating revenue. Especially for this ticker.